ATM and cancer: Hypoxia has been described to drive misregulation of DNA repair and damage response genes, such as Ataxia Telangiectasia mutated (ATM) or ATRX, in cancer cells, and has been shown to increase rates of mutations due to intracellular ROS production [61].